Capstan Medical key facts
as of Oct 2026- Developer of catheter-based technology intended to transform the treatment of structural heart disease.
- Capstan Medical is valued at approximately $367.0M as of Oct 2026 (last reported valuation).
- It has raised $152.8M; the latest was Later Stage VC ($110.0M) in Dec 2024.
- Notable investors include Eclipse Capital, Eclipse Ventures, Puma Venture Capital, Gideon Strategic Partners, Intuitive Ventures — 6 tracked in total.
- Status: Privately Held (backing).
Capstan Medical's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·Watch Capstan Medical: the Monday email on marks, rounds and moves
Capstan Medical funding rounds
No funding rounds for Capstan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Capstan Medical
6Capstan Medical valuation
Capstan Medical's last reported valuation was $367 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Capstan Medical investors
6 investors are on record for Capstan Medical, including Eclipse Capital, Eclipse Ventures, Puma Venture Capital and Gideon Strategic Partners.
About Capstan Medical
Developer of catheter-based technology intended to transform the treatment of structural heart disease. The company offers a less invasive alternative to traditional open heart surgery while ensuring precise and reliable placement of the heart valve implant, enabling doctors to give their patients a solution to their heart valve disease while significantly reducing recovery time and minimizing the risk of complications
- Sector
- Healthcare
- HQ
- Santa Cruz, CA, United States
- Founded
- 2020
- Employees
- 69
- Website
- capstanmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.